CaP Ceramics, Senior Scientist, Bioceramics & Biocompatibility Group
Christoph Stähli obtained a B.Sc. (2007) and M.Sc. (2009) in Materials Science at the Swiss federal institute of technology in Lausanne (EPFL), with a Master’s thesis on the tribocorrosion resistance of a biomedical CoCrMo alloy. From 2009 to 2014, he completed a Ph.D. thesis at McGill University in Montreal, Canada, on the stimulation of angiogenesis (growth of blood vessels) through copper ion release from bioactive glasses.
At RMS Foundation since 2015, he provides materials testing as well as consulting services and conducts research in the field of synthetic calcium phosphate bone substitute materials. He has developed new analytical methods tailored to meet customer’s regulatory requirements, in particular on trace element analysis by means of inductively coupled plasma-mass spectrometry.
In 2018, he obtained a CAS in Management of Biotech, Medtech & Pharma Ventures from EPFL.